Unknown

Dataset Information

0

MUC1 Mucin: A Putative Regulatory (Checkpoint) Molecule of T Cells.


ABSTRACT: T lymphocytes are at the center of inducing an effective adaptive immune response and maintaining homeostasis. T cell responses are initiated through interactions between antigen presenting cells (APCs) and T cells. The type and strength of signals delivered through the T cell receptor (TCR) may modulate how the cells respond. The TCR-MHC (T cell receptor-major histocompatibility complex molecules) complex dictates the specificity, whereas co-stimulatory signals induced by interaction of various accessory cell surface molecules strengthen and optimize T cell responses. Multiple immune regulatory mechanisms brought about by co-inhibitory molecules expressed on T cells play a key role in orchestrating successful and non-damaging immunity. These co-inhibitory molecules are also referred to as initiators of immune check-points or co-inhibitory pathways. Knowledge of co-inhibitory pathways associated with activated T lymphocytes has allowed a better understanding of (a) the inflammatory and anti-inflammatory processes associated with infectious diseases and autoimmune diseases, and (b) mechanisms by which tumors evade immune attack. Many of these regulatory pathways are non-redundant and function in a highly concerted manner. Targeting them has provided effective approaches in treating cancer and autoimmune diseases. For this reason, it is valuable to identify any co-inhibitory molecules that affect these pathways. MUC1 mucin (CD227) has long been known to be expressed by epithelial cells and overexpressed by a multitude of adenocarcinomas. As long ago as 1998 we made a surprising discovery that MUC1 is also expressed by activated human T cells and we provided the first evidence of the role of MUC1 as a novel T cell regulator. Subsequent studies from different laboratories, as well as ours, supported an immuno-regulatory role of MUC1 in infections, inflammation, and autoimmunity that corroborated our original findings establishing MUC1 as a novel T cell regulatory molecule. In this article, we will discuss the experimental evidence supporting MUC1 as a putative regulatory molecule or a "checkpoint molecule" of T cells with implications as a novel biomarker and therapeutic target in chronic diseases such as autoimmunity, inflammation and cancer, and possibly infections.

SUBMITTER: Agrawal B 

PROVIDER: S-EPMC6204366 | biostudies-other | 2018

REPOSITORIES: biostudies-other

altmetric image

Publications

MUC1 Mucin: A Putative Regulatory (Checkpoint) Molecule of T Cells.

Agrawal Babita B   Gupta Nancy N   Konowalchuk Jeffrey D JD  

Frontiers in immunology 20181022


T lymphocytes are at the center of inducing an effective adaptive immune response and maintaining homeostasis. T cell responses are initiated through interactions between antigen presenting cells (APCs) and T cells. The type and strength of signals delivered through the T cell receptor (TCR) may modulate how the cells respond. The TCR-MHC (T cell receptor-major histocompatibility complex molecules) complex dictates the specificity, whereas co-stimulatory signals induced by interaction of various  ...[more]

Similar Datasets

| S-EPMC4057712 | biostudies-literature
| S-EPMC3718471 | biostudies-literature
| S-EPMC3297171 | biostudies-literature
| S-EPMC3252914 | biostudies-literature
| S-EPMC5358667 | biostudies-literature
| S-EPMC3234732 | biostudies-literature
| S-EPMC2688377 | biostudies-literature
| S-EPMC3256590 | biostudies-literature
| S-EPMC6237209 | biostudies-literature
| S-EPMC3538090 | biostudies-literature